Consulting Services
For Investors
Case Studies
Insights
- Conference Coverage
BioPharma and Tech News
LucidSearch
QuickAnswers

Contact Us

Search

Lexeo Therapeutics

Cell_Gene_Therapy

Cell and Gene Therapy Today—October 23, 2025

This week’s Cell and Gene Therapy update spotlights key developments,…

Cell_Gene_Therapy

Cell and Gene Therapy Weekly News - October 9th 2025

Gene & Cell Therapy Update: JCR CNS/Muscle AAV, Lexeo FA Data, RareTx…

Categories

Endocrinology News
Immunology News
Our Insights
Hematology News
Case studies
Oncology News
BioPharma and Tech News
Lucid Diligence Brief
BioPharma Strategy, CI and AI Guides
Conference Coverage
AI in Healthcare and Digital Health
Cell and Gene Therapy News
Rare Disease News
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news
Obesity News

Recent Posts

Lucid Diligence Brief: Lumonus A$25M Series B
AHA 2025 Preview: Key Clinical and AI / ML Highlights to Watch
Respiratory Today—November 7, 2025
Vaccines Today—November 7, 2025
Public Health Video Recap—November 7, 2025

Tags

AAVantgarde Bio ADCs Air Quality bioinformatics biomarin pharmaceutical BridgeBio cancer cardiovascular risk factors cipla Coronary and Structural Interventions corporate venture capital cutaneous T-cell lymphoma Elranatamab erumo ESMO 2021 gene editing gene therapy approval Global Burden of Disease Hanmi HM17321 health systems heart failure congestion hematology HLTH ISP-001 Lantern Pharma Milestone Pharmaceuticals mNSCLC mrsa infection NFTs in healthcare non viral vectors pediatric AD personalized cancer vaccine pharma privacy PSVT Redx Pharma Remyelination respiratory infections Roche Diagnostics Sema4 sGC sk biopharm Sunshine Biopharma TERN-601 tulisokibart

Archives

Archives

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Lucid Diligence Brief: Lumonus A$25M Series B
AHA 2025 Preview: Key Clinical and AI / ML Highlights to Watch
Respiratory Today—November 7, 2025
Vaccines Today—November 7, 2025
Public Health Video Recap—November 7, 2025

TAGS

AAVantgarde Bio ADCs Air Quality bioinformatics biomarin pharmaceutical BridgeBio cancer cardiovascular risk factors cipla Coronary and Structural Interventions corporate venture capital cutaneous T-cell lymphoma Elranatamab erumo ESMO 2021 gene editing gene therapy approval Global Burden of Disease Hanmi HM17321 health systems heart failure congestion hematology HLTH ISP-001 Lantern Pharma Milestone Pharmaceuticals mNSCLC mrsa infection NFTs in healthcare non viral vectors pediatric AD personalized cancer vaccine pharma privacy PSVT Redx Pharma Remyelination respiratory infections Roche Diagnostics Sema4 sGC sk biopharm Sunshine Biopharma TERN-601 tulisokibart

Consulting Services
For Investors
Case Studies
Insights
- Conference Coverage
BioPharma and Tech News
LucidSearch
QuickAnswers

© 2025 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy